Skip to main content

Table 2 MiRNAs diferentially expressed between serum of ccRCC patients and healthy controls

From: Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma

miRNA

Fold change

P-value

Probability, that gene is differentially expressed

hsa-miR-760

169.628

< 0.000001

100.000%

hsa-miR-381

0.002

< 0.000001

100.000%

hsa-miR-378

37.596

< 0.000001

100.000%

hsa-miR-151-3p

35.734

< 0.000001

100.000%

hsa-miR-629

45.790

< 0.000001

100.000%

hsa-miR-150

0.020

< 0.000001

100.000%

hsa-miR-219-5p

0.032

< 0.000001

99.999%

hsa-miR-26b*

41.191

< 0.000001

99.999%

hsa-miR-302b

0.057

< 0.000001

99.997%

hsa-miR-19b-1*

36.432

< 0.000001

99.994%

hsa-miR-126*

9.317

< 0.000001

99.972%

hsa-let-7f

0.011

< 0.000001

99.968%

hsa-miR-571

30.947

< 0.000001

99.978%

hsa-miR-29c*

23.842

< 0.000001

99.976%

hsa-miR-625*

13.286

< 0.000001

99.938%

hsa-let-7a

0.014

< 0.000001

99.922%

hsa-miR-134

40.828

< 0.000001

99.846%

hsa-miR-320

4.533

< 0.000001

99.811%

hsa-miR-451

0.225

< 0.000001

99.723%

hsa-miR-19a

0.261

< 0.000001

99.651%

hsa-miR-365

16.768

< 0.000001

99.642%

hsa-miR-339-3p

10.606

< 0.000001

99.524%

hsa-miR-203

79.565

< 0.000001

98.908%

hsa-miR-302c

0.044

< 0.000001

98.729%

hsa-miR-454*

11.965

< 0.000001

97.193%

hsa-miR-144*

6.425

< 0.00001

92.206%

hsa-miR-655

10.716

< 0.00001

84.080%

hsa-miR-367

0.133

< 0.00001

81.739%

hsa-miR-425*

6.666

< 0.0001

79.234%

hsa-miR-142-5p

0.136

< 0.0001

74.933%

  1. Abbreviations: miR, microRNA/miRNA; ccRCC, clear cell renal cell carcinoma